Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT00387972 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study cancelled before enrollment

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: denagliptin (GW823093)

Sponsor

GlaxoSmithKline